Pharma Industry News

Novartis’ Cosentyx reduces synovitis in new psoriatic arthritis study

Synovitis (joint lining inflammation) can lead to joint damage in psoriatic arthritis patientsOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]